Company
Products & Services
R & D
News & Investors
Careers
Contact
Press Releases 2011
09.12.2011
Epigenomics AG Completes U.S. Clinical Validation Study for Colorectal Cancer Blood Test Epi proColon; Provides Update on U.S. Regulatory Plans
PDF 73 KB
16.11.2011
Epigenomics’ Licensee ARUP Presents Clinical Data for Colorectal Cancer Blood Test at AMP
PDF 48 KB
09.11.2011
Epigenomics AG Announces Q3 Financial Results and Operational Highlights
PDF 63 KB
07.11.2011
Open letter to the editor of “Clinical Gastroenterology and Hepatology” regarding a recently published article in that journal
PDF 77 KB
25.10.2011
Epigenomics announces the European launch of Epi
pro
Colon® 2.0 CE
PDF 65 KB
20.10.2011
SAVE THE DATE: Epigenomics - launch briefing on Epi
pro
Colon® 2.0 CE
PDF 54 KB
19.09.2011
Epigenomics AG reports Epi
pro
Colon® 2.0 finds 95% of cancers in clinical study
PDF 59 KB
10.08.2011
Epigenomics AG Presents Mid-Year Results and Announces Restructuring Plan Heightening Focus on the Key U.S. Market
PDF 111 KB
07.07.2011
Epigenomics AG: Surveys Show That Patients Believe in Blood Tests for Regular Colorectal Cancer Screening
PDF 124 KB
18.05.2011
Epigenomics AG to Suggest Reduction of Share Capital and 5:1 Reverse Stock Split at Upcoming AGM
PDF 38 KB
1-10
11-19
Next >
News & Media
Press Releases
2011
2010
2009
Archive
Ad hoc Releases
Events
Downloads
Request Info
Investors